| Name | Title | Contact Details |
|---|
NovaSom is a Glen Burnie, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Systagenix Wound Management (US) is a Quincy, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Premise Health is here to change the way people see and experience healthcare. We help organizations take healthcare farther – by bringing it closer than ever. We’ve created a worksite health model that achieves better patient engagement, and delivers higher-value programs that sustainably improve health outcomes to worksite and distributed workforces. For employers, this means finally controlling costs – while delivering a leading-edge health benefit that actually benefits health. On behalf of 220+ clients, Premise Health operates over 500 onsite health centers, pharmacies, and fitness centers in 46 states and 2 U.S. territories.
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.
City of Winston-Salem, North Carolina, U.S.A. Local government. Contact City Link call 311; citylink@cityofws.org